Publications

5808 Results

Clinical and molecular characterization of a rare syndrome of acute promyelocytic leukemia associated with translocation (11;17)

Authors
JD Licht;C Chomienne;A Goy;A Chen;AA Scott;DR Head;JL Michaux;Y Wu;A DeBlasio;WH Miller Jr;AD Zelenetz;CL Willman;Z Chen;S-J Chen;A Zelent;E Macintyre;A Veil;J Cortes;H Kantarjian;S Waxman
Journal / Conference
Blood 85(4):1083-1094
Year
1995

Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia.

Authors
B Mehrotra;TI George;K Kavanau;H Avet-Loiseau;D Moore II;Cl Willman;ML Slovak;S Atwater;DR Head;MG Pallavicini
Journal / Conference
Blood 86(3):1139-1147
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8600, SWOG-8750, SWOG-9007, SWOG-9031

Trisomy 11: an association with stem/progenitor cell immunophenotype.

Authors
ML Slovak;ST Traweek;CL Willman;DR Head;KJ Kopecky;RE Magenis;FR Appelbaum;SJ Forman
Journal / Conference
British Journal of Hematology 90:266-273
Year
1995
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8326/27, SWOG-8600, SWOG-9031, SWOG-9034 (EST-3489) (CALGB-9120)

Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: A Southwest Oncology Group study.

Authors
J Rinehart;KA Margolin;P Triozzi;E Hersh;M Campion;D Resta;D Levitt
Journal / Conference
Clinical Cancer Research 1:1139-1144
Year
1995
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-9026

Concurrent cisplatin (CDDP), prolonged oral etoposide (E) and vincristine (VCR) plus chest and brain irradiation (RT) induction therapy for limited-stage small cell lung carcinoma (SCLC): Preliminary report of a Southwest Oncology Group study (SWOG-9229)

Authors
CR Thomas Jr;DJ Rector;KJ Stelzer;RB Livingston
Journal / Conference
ASCO 14:363(#1111)
Year
1995
Research Committee(s)
Lung
Study Number(s)
SWOG-9229

The Intergroup Study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer.

Authors
CG Moertel;TR Fleming;JS Macdonald;DG Haller;JA Laurie;CM Tangen;JS Ungerleider;WA Emerson;DC Tormey;JH Glick;MH Veeder;JA Mailliard
Journal / Conference
Journal of Clinical Oncology 13(12):2936-2943
Year
1995
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8591(NCI Intergroup #0035)

Phase III study of intraperitoneal (IP) cisplatin (CDDP)/intravenous (IV) cyclophosphamide (CPA) vs IV CDDP/IV CPA in patients (pts) with optimal disease stage III ovarian cancer: A SWOG-GOG-ECOG Intergroup Study (INT-0051)

Authors
DS Alberts;PY Liu;EV Hannigan;R O'Toole;SD Williams;J Young;EW Franklin;D Clarke-Pearson;VK Malviya;S DuBeshter;W Hoskins;M Adelson;RD Alvarez;S Vogel;J O'Sullivan;DJ Garcia;D Sparks;ML Rothenberg
Journal / Conference
ASCO 14:273(#760)
Year
1995
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-8501 (INT-0051)

A Southwest Oncology Group (SWOG) analysis of the anaplastic large cell lymphoma (ALCL) entities in the revised European American lymphoma (REAL) classification.

Authors
T Grogan;C Kjeldsberg;R Tubbs;S Dahlberg;R Braziel;C Foucar;C Leith;C Spier;E Gaynor;T Miller;R Fisher
Journal / Conference
International Academy of Pathology Book of Abstracts :111A(#644)
Year
1995
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8516 (INT-0067), SWOG-8819

Tumor infiltrating lymphocytes (TILs) instage I cutaneous melanoma: A Southwest Oncology Group study.

Authors
RJ Tuthill;DJ Rector;VK Sondak;PY Liu;FL Meyskens
Journal / Conference
International Academy of Pathology Book of Abstracts :51A(#284)
Year
1995
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8049

Evaluation of multimodality treatment of locoregional esophageal carcinoma: SWOG 9060.

Authors
E Poplin;A Herskovic;J Jacobson;T Panella;J Macdonald
Journal / Conference
ASCO 14:202(#486)
Year
1995
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9060